Gene therapy for genetic and acquired retinal diseases

被引:25
作者
Chaum, E
Hatton, MP
机构
[1] Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol, Memphis, TN 38163 USA
[2] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA
[3] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA
[4] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA
关键词
apoptosis; gene therapy; growth factors; proliferative vitreoretinopathy; retinal pigment epithelium retina; retinal degeneration; retinitis pigmentosa; retinoblastoma; ribozymes; transfection; viruses;
D O I
10.1016/S0039-6257(02)00336-3
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
We present an overview of the current status of basic science and translational research being applied to gene therapy for eye disease, focusing on diseases of the retina. We discuss the viral and nonviral methods being used to transfer genes to the retina and retinal pigment epithelium, and the advantages and disadvantages of each approach. We review the various genetic and somatic treatment strategies that are being used for genetically determined and acquired diseases of the retina, including gene replacement, gene silencing by ribozymes and antisense oligonucleotides, suicide gene therapy, antiapoptosis, and growth factor therapies. The rationales for the specific therapeutic approaches to each disease are discussed. Schematics of gene transfer methods and therapeutic approaches are presented together with a glossary of gene transfer terminology. (C) 2002 by Elsevier Science Inc. All rights reserved.
引用
收藏
页码:449 / 469
页数:21
相关论文
共 232 条
[21]  
Bennett J, 1997, INVEST OPHTH VIS SCI, V38, P2857
[22]  
BENNETT J, 1994, INVEST OPHTH VIS SCI, V35, P2535
[23]   Humoral response after administration of E1-deleted adenoviruses: Immune privilege of the subretinal space [J].
Bennett, J ;
Pakola, S ;
Zeng, Y ;
Maguire, A .
HUMAN GENE THERAPY, 1996, 7 (14) :1763-1769
[24]   Adenovirus-mediated delivery of rhodopsin-promoted bcl-2 results in a delay in photoreceptor cell death in the rd/rd mouse [J].
Bennett, J ;
Zeng, Y ;
Bajwa, R ;
Klatt, L ;
Li, Y ;
Maguire, AM .
GENE THERAPY, 1998, 5 (09) :1156-1164
[25]  
BENNETT J, 2000, RETINAL GENE THERAPY
[26]  
BENNETT J, 1999, AGE RELATED MACULAR, P395
[27]   Molecular genetics and prospects for therapy of the inherited retinal dystrophies [J].
Bessant, DAR ;
Ali, RR ;
Bhattacharya, SS .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2001, 11 (03) :307-316
[28]   IN-VITRO EVIDENCE THAT METABOLIC COOPERATION IS RESPONSIBLE FOR THE BYSTANDER EFFECT OBSERVED WITH HSV TK RETROVIRAL GENE-THERAPY [J].
BI, WL ;
PARYSEK, LM ;
WARNICK, R ;
STAMBROOK, PJ .
HUMAN GENE THERAPY, 1993, 4 (06) :725-731
[29]   The structure, function and application of the hammerhead ribozyme [J].
Birikh, KR ;
Heaton, PA ;
Eckstein, F .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 245 (01) :1-16
[30]  
BLANKS JC, 2000, MACULAR SURG, P260